Natco Pharma launches 'Pemnat' for curing lung cancer

New Delhi, Nov 28 (UNI) Natco Pharma Ltd today announced the launch of Pemetrexed, to be used in the treatment of locally advanced or malignant non-small cell lung cancer.

It would be available under the brand name of Pemnat and sold in 20 ml vial injections.

The drug will cost around Rs 25,500 per vial as against the imported medicine costing around Rs 79,000.

Prescribed after prior chemotherapy, the availability of Pemnat enhances the treatment options for non-small cell lung cancer. It is also useful in the treatment of malignant pleural mesothelioma in patients where curative surgery cannot be performed.

UNI DKS SRS VV1630